Is Korsana Biosciences, Inc. a good investment? Korsana Biosciences, Inc. (KRSA) is currently trading at 34.99 USD. Market analysts have a consensus price target of 35.33 USD. This suggests a potential upside from current levels.
Earnings Schedule: Korsana Biosciences, Inc. is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is -3.56.
No, it does not currently pay a dividend.
Korsana Biosciences, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of -7.07.
Korsana Biosciences, Inc., a biotechnology company that discovers and develops novel therapies for neurodegenerative diseases. The company was incorporated in 2024 and is based in Waltham, Massachusetts.
| Split Date | Split Ratio to 1 |
|---|---|
| May 16, 2023 | 1:20 |
| Sept. 9, 2026 | 1:7 |
Community Discussion